Previous Page  32 / 44 Next Page
Information
Show Menu
Previous Page 32 / 44 Next Page
Page Background

32

Bibliografía

1. Feagan BG, Reinisch W, Rutgeerts P, Sandborn WJ, Yan S, Eisenberg D, et al. The effects of infliximab therapy on health-related

quality of life in ulcerative colitis patients. Am J Gas-troenterol

2007; 102: 794-802

.

2. Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP, et al. Effects of adalimumab maintenance therapy on health-

related quality of life of patients with Crohn’s disease: pa-tient-reported outcomes of the CHARM trial. Am J Gastroenterol

2008; 103: 3132-41.

3. Kamm MA, Hanauer SB, Rutgeerts P, Colombel W, Sandborn WJ, Lomax KG, et al. Results from an open-label extension of

CHARM: steroid-free remission in patients with Crohn’s dis-ease who received adalimumab therapy for at least 3 years.

Gastroenterology 2009; 136: A653.

4. Loftus EV, Rubin DT, Chen N, Mulani P, Chao J. Remission and quality of life improvements sustained with adalimumab in anti-

TNF-naive patients with Crohn’s disease: 3 year data from CHARM. Gastroenterology 2009; 136: A180.

5. Cohen RD. The quality of life in patients with Crohn’s disease. Aliment Pharmacol Ther 2002; 16: 1603-9.

6. Ceballos D. Niveles de biológicos: eficacia e inmunogenicidad del tratamiento para enfermedad inflamatoria intestinal [Tesis

doctoral]. Universidad de Las Palmas de Gran Canaria; 2015.

7. Mitchell A, Guyatt G, Singer J, Irvine EJ. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol 1988;

10: 306-10.

8. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in

inflammatory bowel disease. Gastroenterology 1989; 96: 804-10.

9. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992; 14: 15-9.

10.Lopez Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada J-R. Validation of the Spanish version of the Inflammatory Bowel

Disease Questionnaire in ulcerative colitis and Crohn’s disease. Digestion 1999: 60: 274-80.

11.Hlavaty T, Persoons P, Vermeire S, Ferrante M, Pierik M, Van Assche G, et al. Evaluation of short-term responsiveness and cut-

off values of inflammatory bowel disease questionnaire in Crohn’s disease. Inflamm Bowel Dis 2006; 12: 199-204.

12.Alcala MJ, Casellas F, Fontanet G, Prieto L, Malagelada JR. Shortened questionnaire on quality of life for inflammatory bowel

disease. Inflamm Bowel Dis 2004; 10: 383-91.

13.Casellas F, Alcala MJ, Prieto L, Miro JR, Malagelada JR. Assessment of the influence of disease activity on the quality of life of

patients with inflammatory bowel disease using a short questionnaire. Am J Gastroenterol 2004; 99: 457-61.

14.Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Influence of inflammatory bowel disease on different

dimensions of quality of life. Eur J Gastroenterol Hepatol 2001; 13: 567-72.

15.Iglesias M, Vázquez I, Barreiro-de Acosta M, Figueiras A, Nieto L, Piñeiro M et al. Health related quality of life in patients with

Cohn´s disease in remission. Rev Esp Enferm Dig. 2010 Nov; 102(11): 624-30.

16.Larsson K, Lööf L, Rönnblom A, et al. Quality of life for patients with exacerbation in inflammatory bowel disease and how

they cope with disease activity. J Psychosom Res. 2008; 64: 139–48.

17.Lix LM, Graff LA, Walker JR, et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and

inactive disease patterns in inflammatory bowel disease. Inflamm. Bowel Dis. 2008; 14: 1575–84.

18.Blondel-Kucharski F, Chircop C, Marquis P, et al. Health-related quality of life in Crohn’s disease: a prospective longitudinal

study in 231 patients. Am. J. Gastroenterol. 2001; 96: 2915–20.

19.Casellas F, López-Vivancos J, Casado A, et al. Factors affecting health related quality of life of patients with inflammatory

bowel disease. Qual Life Res. 2002; 11: 775–81.

20.Haapamäki J, Turunen U, Roine RP, et al. Impact of demographic factors, medication and symptoms on disease-specific quality

of life in inflammatory bowel disease. Qual Life Res. 2009; 18: 961–69.

revisión monográfica

Impacto psicológico en la Enfermedad Inflamatoria

Intestinal: no tan secundario